Fallopian Tube Cancer News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Niraparib Approved in Europe for Ovarian Cancer - OncLive



PharmaTimes
 
Niraparib Approved in Europe for Ovarian Cancer 
OncLive
The European Commission has approved niraparib (Zejula) as a maintenance therapy for women with platinum-sensitive relapsed high-grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in complete or partial response to ...
EU approves post-chemo option for patients with ovarian cancer ... PharmaTimes

all 2 news articles » 


Some aggressive ovarian cancers start in the fallopian tubes, not the ovaries - Cancer Research UK



Cancer Research UK
 
Some aggressive ovarian cancers start in the fallopian tubes, not the ovaries 
Cancer Research UK
The scientists also collected samples from women who were deemed at high risk of developing ovarian cancer and had their ovaries and fallopian tubes removed. They studied STIC lesions and normal tissue from 4 women, three of whom had a BRCA gene ...
Most ovarian cancers get their start in fallopian tubes Futurity: Research News
Scientists track Ovarian cancers to site of origin : Fallopian Tubes ... ETHealthworld.com
Scientists might have been looking for ovarian cancer in the wrong ... The Independent
TheHealthSite  -U.S. News & World Report  -Malay Mail Online 
all 9 news articles » 


New Evidence Suggests Ovarian Cancer Might Not Start in The Ovaries - ScienceAlert



New Evidence Suggests Ovarian Cancer Might Not Start in The Ovaries 
ScienceAlert
A new study looking at how ovarian cancer starts has suggested it takes hold in the fallopian tubes, between the ovaries and the uterus, rather than in the ovaries themselves. This discovery could transform the way we detect and treat this deadly disease.
Ovarian cancer 'may begin in fallopian tubes' International Federation of Gynecology and Obstetrics

all 20 news articles » 


What causes ovarian cancer? New study suggests the root may be ... - The Hub at Johns Hopkins



The Hub at Johns Hopkins
 
What causes ovarian cancer? New study suggests the root may be ... 
The Hub at Johns Hopkins
The root of many ovarian tumors may be found in the fallopian tubes, a new study from Johns Hopkins suggests. The findings provide potential insights into the ...
Ovarian cancer may actually arise in Fallopian tubes - The San ... The San Diego Union-Tribune
Discovery that Ovarian Cancer Originates in Fallopian Tubes May Aid Earlier Diagnosis Genetic Engineering & Biotechnology News (press release)

all 5 news articles » 


Mutation in fallopian tube lesions may help catch ovarian cancer ... - EurekAlert (press release)



New York Daily News
 
Mutation in fallopian tube lesions may help catch ovarian cancer ... 
EurekAlert (press release)
Screening for tumor cells in the fallopian tubes of women at high-risk for ovarian cancer may help detect the cancer years before it develops further, suggests a ...
Ovarian cancer might not start where we think it does - NY Daily News New York Daily News
Ovarian cancer develops in fallopian tubes for over 6 years, before being detected Deccan Chronicle

all 3 news articles » 


Fallopian Tube Mutation Could Lead to Early Diagnosis of Ovarian Cancer - Specialty Pharmacy Times



Fallopian Tube Mutation Could Lead to Early Diagnosis of Ovarian Cancer 
Specialty Pharmacy Times
Previous studies in mice and humans have shown that cancer can start in the fallopian tubes and spread to the ovaries, which is typically when the condition is diagnosed. Currently, it is unknown how and when these cancers develop and how to catch it ...

 


Fallopian Tube Cancer Market Analysis 2017 to 2025 - Research of Market



Fallopian Tube Cancer Market Analysis 2017 to 2025 
Research of Market
Fallopian Tube Cancer-Mechanism of action Insights, 2017?, report provides comprehensive insights of the ongoing therapeutic research and development across Fallopian Tube Cancer. The report provides a complete understanding of the pipeline ...

and more » 


Biotech Stock Roundup: RARE drug Gets FDA Nod, Acorda, Cytokinetics Hit by Pipeline Setbacks - Nasdaq



Biotech Stock Roundup: RARE drug Gets FDA Nod, Acorda, Cytokinetics Hit by Pipeline Setbacks 
Nasdaq
... the maintenance treatment of adult patients with platinum-sensitive relapsed high grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in complete response ("CR") or partial response ("PR") to platinum-based ...

and more » 


Fallopian Tube Cancer Market Research Report H2: Drug Profile, Top Industry Intelligence and Therapeutic ... - satPRnews (press release)



Fallopian Tube Cancer Market Research Report H2: Drug Profile, Top Industry Intelligence and Therapeutic ... 
satPRnews (press release)
Fallopian Tube Cancer Market? Pipeline Review, H2 analysis report speaks about keyplayers with pipeline review and targeted therapeutics covering drugs profile, Symptoms and Treatment includes of Fallopian Tube Cancer industry. The report also covers ...

and more » 


Aminopeptidase N-Therapeutics Development in depth with Future Prospects by Leading Key Players- MolMed SpA ... - Medgadget (blog)



Medgadget (blog)
 
Aminopeptidase N-Therapeutics Development in depth with Future Prospects by Leading Key Players- MolMed SpA ... 
Medgadget (blog)
Report covers products from therapy areas Central Nervous System, Oncology, Cardiovascular and Hematological Disorders which include indications Cancer Pain, Pain, Acute Pain, Diabetic Neuropathic Pain, Fallopian Tube Cancer, Gastric Cancer, ...